36 results
8-K
EX-99.1
PROK
ProKidney Corp - Ordinary Shares
10 May 24
ProKidney Reports Business Updates and First Quarter 2024 Financial Results
7:05am
Strengthened leadership team with appointment of two key hires across Clinical and Technical Operations
Ended the first quarter with $329 million in cash … , the Company announced Dr. Ernst joined as EVP of Technical Operations and as part of the ProKidney Executive Leadership Team. Dr. Ernst brings over
8-K
EX-99.1
PROK
ProKidney Corp - Ordinary Shares
25 Mar 24
ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations
4:07pm
Exhibit 99.1
ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations
Dr. Ulrich Ernst joins as Executive … cellular therapeutics company focused on chronic kidney disease (CKD), today announced two recent strategic appointments enhancing the leadership team’s
8-K
EX-99.1
PROK
ProKidney Corp - Ordinary Shares
21 Mar 24
ProKidney Reports Full Year 2023 Financial Results and Recent Corporate Highlights
8:00pm
with kidney disease and held executive leadership positions at Baxter Healthcare and CVS Kidney Care, a wholly owned subsidiary of CVS Health
8-K
EX-99.1
l3e24gnp88
26 Jan 24
Regulation FD Disclosure
12:00am
8-K
s81184yq8rdj zijnu
30 Nov 23
Departure of Directors or Certain Officers
6:58am
8-K
EX-99.2
mgb81nn5gkgo
13 Nov 23
Departure of Directors or Certain Officers
5:28pm
8-K
8zybj6
13 Nov 23
Departure of Directors or Certain Officers
5:28pm
8-K
EX-99.1
xumwqbldqf gumbi
11 Sep 23
Regulation FD Disclosure
8:01am
DEF 14A
mfqnkc2l
26 May 23
Definitive proxy
8:00am
424B3
d4m w8ohekwnfzbx
21 Apr 23
Prospectus supplement
4:18pm
POS AM
vc06d2n2rc
17 Apr 23
Prospectus update (post-effective amendment)
5:01pm
424B3
yrckh4n06
9 Sep 22
Prospectus supplement
5:05pm
8-K
EX-99.1
kcgtbj4
8 Sep 22
Regulation FD Disclosure
6:55am
8-K
EX-99.1
an8 umoge
11 Aug 22
ProKidney Corp. Reports Second Quarter 2022 Financial Results and Provides Business Update
5:41pm